Powered by: Motilal Oswal
2026-10-30 12:18:35 pm | Source: Accord Fintech
Shelter Pharma trades higher on bagging export orders worth Rs 3.47 crore
Shelter Pharma trades higher on bagging export orders worth Rs 3.47 crore

Shelter Pharma is currently trading at Rs. 41.64, up by 1.14 points or 2.81% from its previous closing of Rs. 40.50 on the BSE.

The scrip opened at Rs. 42.47 and has touched a high and low of Rs. 42.49 and Rs. 41.64 respectively. So far 18000 shares were traded on the counter.

The BSE group 'MT' stock of face value Rs. 10 has touched a 52 week high of Rs. 55.88 on 13-Oct-2026 and a 52 week low of Rs. 23.00 on 09-Jul-2026.

Last one week high and low of the scrip stood at Rs. 45.70 and Rs. 39.60 respectively. The current market cap of the company is Rs. 73.52 crore.

The promoters holding in the company stood at 44.60%, while Non-Institutions held 55.40% stake in the company.

Shelter Pharma has secured export orders around Rs 3.47 crore from multiple customers. It has secured an order worth around Rs 3.15 crore from Taha Drugs & Chemicals for Joemega Capsules, Foliman Tablet and All Vitamin Tablet. Further, it has secured an order worth around Rs 22.19 lakh from First Vet Veterinary Medicines for Electrolyte Dex C, Lactocal Gel Super and Livodin-12 Liquid.

Additionally, the company has secured an order worth around Rs 9.58 lakh from Genet International for IMMUNO UP, NGK FORTE and BUTA-B BOLUS.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here